VANCOUVER, BC, July 29, 2021 /CNW/ – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the…
Category: Nova Mentis
Nova Mentis Appoints Dr. Stephen Glazer as Director and Chief Science Officer
VANCOUVER, BC, July 15, 2021 /CNW/ – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the…
Nova Mentis Autism Clinical Study Approved by Canadian Institutional Review Board
VANCOUVER, BC, June 23, 2021 /CNW/ – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the…
Nova Mentis Launches Autism Clinical Study
VANCOUVER, BC, May 6, 2021 /CNW/ – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the…
Nova Mentis Organizes Autism Data Bank in North America
VANCOUVER, BC, April 20, 2021 /CNW/ – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the…
Nova Mentis Establishes Serotonin Research Centre
New Partnership with FourthWall Testing VANCOUVER, BC, March 31, 2021 /CNW/ – Nova Mentis Life Science Corp. (CSE: NOVA)…
Nova Mentis Announces Promising Research Results
Psilocybin formulation Modulates Anxiety-Like Behaviour in Rat Autism Model VANCOUVER, BC, March 29, 2021 /CNW/ – Nova Mentis Life…
Nova Mentis Launches Autism Microbiome Study in the United States
VANCOUVER, BC, March 3, 2021 /CNW/ – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the…
Nova Mentis Autism Clinical Study Approved by Institutional Review Board
VANCOUVER, BC, Feb. 25, 2021 /CNW/ – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”),…
Nova Mentis Expands Pre-Clinical Development Pipeline; Company Begins Fragile X Syndrome Treatment with its Proprietary Psilocybin Drug
VANCOUVER, BC, Feb. 18, 2021 /CNW/ – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the…
Nova Mentis Appoints Gary R. Harlem to Scientific Advisory Board
VANCOUVER, BC, Feb. 11, 2021 /CNW/ – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) (“NOVA” or the…
Nova Mentis Psilocybin Approved for Shipment to Italy
VANCOUVER, BC, Feb. 9, 2021 /CNW/ – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) (“NOVA” or the…